In another study investigating resectable NSCLC, 86.07%, 7.11%, 5.04%, and 1.78% of the EGFR mutations were categorized into classical-like, PACC, Ex20ins-L, and T790M-like groups, respectively [13]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.